These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 9052581

  • 21. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [Abstract] [Full Text] [Related]

  • 22. Pharmacokinetic profiles up to 12 h after administration of vaginal, sublingual and slow-release oral misoprostol.
    Aronsson A, Fiala C, Stephansson O, Granath F, Watzer B, Schweer H, Gemzell-Danielsson K.
    Hum Reprod; 2007 Jul; 22(7):1912-8. PubMed ID: 17488782
    [Abstract] [Full Text] [Related]

  • 23. Steady-state pharmacokinetics of conjugated equine estrogens in healthy, postmenopausal women.
    Mayer P, Tse S, Sendi M, Bourg D, Morrison D.
    J Reprod Med; 2008 Feb; 53(2):97-101. PubMed ID: 18357800
    [Abstract] [Full Text] [Related]

  • 24. Nasal absorption and metabolism of progesterone and 17 beta-estradiol in the rat.
    Bawarshi-Nassar RN, Hussain AA, Crooks PA.
    Drug Metab Dispos; 1989 Feb; 17(3):248-54. PubMed ID: 2568904
    [Abstract] [Full Text] [Related]

  • 25. Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.
    Yasui T, Uemura H, Umino Y, Takikawa M, Saito S, Kuwahara A, Matsuzaki T, Maegawa M, Furumoto H, Miura M, Irahara M.
    Maturitas; 2005 Jan 10; 50(1):19-29. PubMed ID: 15590210
    [Abstract] [Full Text] [Related]

  • 26. Comparison of estrogen and androgen levels after oral estrogen replacement therapy.
    Slater CC, Zhang C, Hodis HN, Mack WJ, Boostanfar R, Shoupe D, Paulson RJ, Stanczyk FZ.
    J Reprod Med; 2001 Dec 10; 46(12):1052-6. PubMed ID: 11789085
    [Abstract] [Full Text] [Related]

  • 27. Sublingual absorption of micronized 17beta-estradiol.
    Burnier AM, Martin PL, Yen SS, Brooks P.
    Am J Obstet Gynecol; 1981 May 15; 140(2):146-50. PubMed ID: 6786097
    [Abstract] [Full Text] [Related]

  • 28. A comparison of serum oestrogen levels after percutaneous and oral administration of oestradiol-17 beta.
    Lyrenäs S, Carlström K, Bäckström T, von Schoultz B.
    Br J Obstet Gynaecol; 1981 Feb 15; 88(2):181-7. PubMed ID: 7459307
    [Abstract] [Full Text] [Related]

  • 29. Pharmacokinetics of estradiol, progesterone, testosterone and dehydroepiandrosterone after transbuccal administration to postmenopausal women.
    Wren BG, Day RO, McLachlan AJ, Williams KM.
    Climacteric; 2003 Jun 15; 6(2):104-11. PubMed ID: 12841880
    [Abstract] [Full Text] [Related]

  • 30. Bioavailability of norethisterone acetate alone and in combination with estradiol administered in single or multiple oral doses to postmenopausal women.
    Stadberg E, Westlund P, Landgren BM, Aedo AR, Cekan SZ, Mattsson LA.
    Maturitas; 1999 Sep 24; 33(1):59-69. PubMed ID: 10585174
    [Abstract] [Full Text] [Related]

  • 31. Characterization of a 7 day 17 beta-estradiol transdermal delivery system: pharmacokinetics in healthy postmenopausal women.
    Boyd RA, Zegarac EA, Eldon MA, Sedman AJ, Forgue ST.
    Biopharm Drug Dispos; 1996 Aug 24; 17(6):459-70. PubMed ID: 8866037
    [Abstract] [Full Text] [Related]

  • 32. Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17 beta-estradiol: comparison with conventional oral estrogens used for hormone replacement.
    Powers MS, Schenkel L, Darley PE, Good WR, Balestra JC, Place VA.
    Am J Obstet Gynecol; 1985 Aug 15; 152(8):1099-106. PubMed ID: 2992279
    [Abstract] [Full Text] [Related]

  • 33. The pharmacokinetics of intravenous estradiol--a preliminary study.
    White CM, Ferraro-Borgida MJ, Fossati AT, McGill CC, Ahlberg AW, Feng YJ, Heller GV, Chow MS.
    Pharmacotherapy; 1998 Aug 15; 18(6):1343-6. PubMed ID: 9855336
    [Abstract] [Full Text] [Related]

  • 34. Pharmacokinetics of Sublingual Versus Oral Estradiol in Transgender Women.
    Doll E, Gunsolus I, Thorgerson A, Tangpricha V, Lamberton N, Sarvaideo JL.
    Endocr Pract; 2022 Mar 15; 28(3):237-242. PubMed ID: 34781041
    [Abstract] [Full Text] [Related]

  • 35. Different effects of oral conjugated equine estrogens and transdermal estrogen on undercarboxylated osteocalcin concentration in postmenopausal women.
    Yasui T, Uemura H, Tomita J, Umino Y, Yamada M, Kuwahara A, Matsuzaki T, Maegawa M, Miura M, Irahara M.
    Menopause; 2006 Mar 15; 13(4):651-9. PubMed ID: 16837887
    [Abstract] [Full Text] [Related]

  • 36. Effects of the route of estrogen administration on insulinlike growth factor-I, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study.
    Davis SR, Stuckey BG, Norman RJ, Papalia MA, Drillich A, Bell RJ.
    Menopause; 2008 Mar 15; 15(6):1065-9. PubMed ID: 18806686
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Pharmacokinetics and pharmacodynamics of a novel estrogen delta8-estrone in postmenopausal women and men.
    Bhavnani BR, Cecutti A, Gerulath A.
    J Steroid Biochem Mol Biol; 1998 Oct 15; 67(2):119-31. PubMed ID: 9877212
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.